Market Cap : 32.73 B | Enterprise Value : 33.99 B | PE Ratio : 45.29 | PB Ratio : 3.00 |
---|
NAS:ILMN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:ILMN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2022-08-13), Illumina's share price is $208.325. Illumina's Owner Earnings per Share (TTM) ended in Mar. 2022 was $3.13. It's Price-to-Owner-Earnings for today is 66.56.
The historical rank and industry rank for Illumina's Price-to-Owner-Earnings or its related term are showing as below:
During the past 13 years, the highest Price-to-Owner-Earnings of Illumina was 116.41. The lowest was 20.62. And the median was 61.15.
As of today (2022-08-13), Illumina's share price is $208.325. Illumina's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 was $4.60. Therefore, Illumina's PE Ratio for today is 45.29.
As of today (2022-08-13), Illumina's share price is $208.325. Illumina's EPS without NRI for the trailing twelve months (TTM) ended in was $4.60. Therefore, Illumina's PE Ratio without NRI for today is 45.29.
During the past 13 years, Illumina's highest PE Ratio without NRI was 202.38. The lowest was 32.02. And the median was 64.45.
The historical data trend for Illumina's Price-to-Owner-Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Illumina's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Price-to-Owner-Earnings distribution charts can be found below:
* The bar in red indicates where Illumina's Price-to-Owner-Earnings falls into.
In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
Illumina's Price-to-Owner-Earnings for today is calculated as
Price-to-Owner-Earnings | = | Share Price | / | Owner Earnings per Share (TTM) |
= | 208.325 | / | 3.13 | |
= | 66.56 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For how to get Owner Earnings per Share (TTM), please click.
Thank you for viewing the detailed overview of Illumina's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.
Frank John Edward | officer: Chief Public Affairs Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Rollins Carissa | officer: SVP, Chief Information Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Pegels Kevin Carl | officer: Chief of Global Operations | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Torres Jose | officer: VP, Chief Accounting Officer | 1300 W. 120TH AVENUE WESTMINSTER CO 80234 |
Reeves Kathryne Gambrell | officer: SVP, Chief Marketing Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Aravanis Alexander | officer: SVP, Chief Technology Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Gottlieb Scott | director | MOLECULAR INSIGHT PHARMACEUTICALS 160 SECOND STREET CAMBRIDGE MA 02142 |
Febbo Phillip G. | officer: SVP Chief Medical Officer | C/O GENOMIC HEALTH, INC. 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063 |
Tousi Susan H | officer: SVP Product Development | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Goswami Joydeep | officer: SVP Corp Business Development | SUMITOMO FUDOSAN MITA TWIN BLDG EAST WING 4-2-8 SHIBAURA MINATO-KU TOKYO M0 1080023 |
Siegel Susan E | director | 3000 SAND HILL ROAD BLDG 3 STE 290 MENLO PARK CA 94025 |
Ragusa Robert P | officer: SVP, Global Quality & Ops | |
Hoyt Aimee L | officer: SVP, Chief People Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Guthart Gary S | director | C/O INTUITIVE SURGICAL INC 1266 KIFER RD SUNNYVALE CA 94086 |
Mcginnis Karen K | officer: VP, Chief Accounting Officer | INSIGHT ENTERPRISES INC 1305 WEST AUTO DRIVE TEMPE AZ 85284 |
Other Sources
By Zacks 2022-02-11
By Zacks 2022-01-24
By Zacks 2022-02-10
By Zacks 2022-02-09
By Zacks 2022-02-16
By Zacks 2022-02-07
By Fool 2022-01-22
By Zacks 2022-01-12
By Zacks 2022-01-07
By Seekingalpha 2022-03-07
By Zacks 2022-01-11
By Zacks 2022-03-14
By tipranks.com 2022-03-02
By Zacks 2022-01-14
By Zacks 2022-02-03